Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar Instbuying (33.04) Submitted: 11/30/2010 6:58:10 AM : Outperform Start Price: $4.80 SVA Score: -68.95

11-29 it 188, sh 1.89

Featured Broker Partners


Advertisement